Sold by: Modus CreateÂ
Transform raw data into actionable insights to accelerate drug discovery, enhance R&D efficiency, and unlock the full potential of AI in life sciences.
Overview
Analyzing massive datasets in drug discovery is time-consuming and delays decision-making, reducing research efficiency and slowing the development of new therapies. To truly unlock the potential of AI in life sciences, organizations need a solid foundation of clean, organized, and actionable data. Modus Create’s AI-Powered Research and Development Insights Solution, built on AWS, addresses these challenges by transforming raw data into a foundation for advanced AI applications. The solution enables real-time analysis, predictive modeling for drug efficacy, and AI-driven compound identification, empowering researchers to make faster, data-driven decisions. By leveraging AWS’s advanced data and AI services, this solution accelerates drug discovery, enhances R&D efficiency, and helps bring new therapies to market faster.
Highlights
- Faster Drug Discovery: Leverage AI for quicker identification of promising compounds.
- Real-Time Analysis: Make data-driven decisions with real-time insights.
- Enhanced R&D Efficiency: Reduce time-to-insight and streamline research processes.
Details
Sold by
Delivery method
Deployed on AWS
Unlock automation with AI agent solutions
Fast-track AI initiatives with agents, tools, and solutions from AWS Partners.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.